002872 ST天聖製藥
按盤價 
5.470 +0.040 (+0.737%)
5.470 +0.040 (+0.737%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.503 | -2.801 | -4.267 | -4.355 | -4.065 |
| 總資產報酬率 ROA (%) | -0.373 | -2.060 | -3.151 | -3.220 | -2.974 |
| 投入資產回報率 ROIC (%) | -0.416 | -2.317 | -3.574 | -3.701 | -3.376 | 邊際利潤分析 |
| 銷售毛利率 (%) | 47.902 | 49.116 | 47.652 | 47.083 | 56.574 |
| 營業利潤率 (%) | -6.794 | -12.271 | -16.505 | -16.152 | -13.955 |
| 息稅前利潤/營業總收入 (%) | -5.259 | -11.228 | -16.092 | -15.196 | -12.495 |
| 淨利潤/營業總收入 (%) | -7.450 | -10.895 | -15.472 | -16.176 | -15.083 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 204.753 | 105.862 | 73.922 | 101.621 | 125.389 |
| 價值變動淨收益/利潤總額(%) | -19.918 | -10.106 | -16.938 | -2.123 | -5.850 |
| 營業外收支淨額/利潤總額(%) | 1.454 | -2.027 | 3.843 | 1.214 | -0.701 | 償債能力分析 |
| 流動比率 (X) | 1.289 | 1.635 | 1.955 | 1.520 | 1.469 |
| 速動比率 (X) | 1.103 | 1.391 | 1.658 | 1.221 | 1.234 |
| 資產負債率 (%) | 25.312 | 25.921 | 26.380 | 25.445 | 26.360 |
| 帶息債務/全部投入資本 (%) | 11.709 | 11.576 | 10.473 | 6.826 | 7.155 |
| 股東權益/帶息債務 (%) | 706.767 | 715.236 | 788.791 | 1,244.126 | 1,188.356 |
| 股東權益/負債合計 (%) | 293.930 | 284.670 | 277.872 | 292.414 | 278.749 |
| 利息保障倍數 (X) | -3.216 | -14.064 | -15.000 | -13.169 | -9.164 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 73.686 | 81.603 | 84.235 | 90.600 | 92.643 |
| 存貨周轉天數 (天) | 129.045 | 143.204 | 146.673 | 156.822 | 174.443 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 08/05/2026 09:47 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
